A Pan-KRAS Inhibitor Impedes Common KRAS Oncoproteins and Tumor Growth
- PMID: 37294122
- DOI: 10.1158/2159-8290.CD-RW2023-090
A Pan-KRAS Inhibitor Impedes Common KRAS Oncoproteins and Tumor Growth
Abstract
A pan-KRAS inhibitor is selec-tive for the inactive state of multiple KRAS mutants, sparing other RAS isoforms.
©2023 American Association for Cancer Research.
Comment on
-
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth.Nature. 2023 Jul;619(7968):160-166. doi: 10.1038/s41586-023-06123-3. Epub 2023 May 31. Nature. 2023. PMID: 37258666 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
